The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
We had a second company do an analysis on my microbiome where they found looking at over 200,000 papers on the microbiome using AI tools. They couldn't find any dispiosis. So there was no disease signature in my entire microbiome, which put me in the in the top 10% of all microbiomes I've ever sampled with that signature. So very very rare.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.